Details
Stereochemistry | ACHIRAL |
Molecular Formula | C5H5N5O |
Molecular Weight | 151.1261 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(N=CN2)C(=O)N1
InChI
InChIKey=UYTPUPDQBNUYGX-UHFFFAOYSA-N
InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)
Molecular Formula | C5H5N5O |
Molecular Weight | 151.1261 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Inactivation of O6-alkylguanine-DNA alkyltransferase by 8-substituted O6-benzylguanine analogs in mice. | 2001 |
|
125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. | 2001 |
|
Base sequence-specific attack of stilbene estrogen metabolite(s) on the mitochondrial DNA: implications in the induction of instability in the mitochondrial genome in the kidney of Syrian hamsters. | 2001 Apr |
|
Reduction of BCNU toxicity to lung cells by high-level expression of O(6)-methylguanine-DNA methyltransferase. | 2001 Apr |
|
Kinetic and mechanistic properties of biotin sulfoxide reductase. | 2001 Feb 6 |
|
Thermodynamics of ion-induced RNA folding in the hammerhead ribozyme: an isothermal titration calorimetric study. | 2001 Feb 6 |
|
Fidelity of nucleotide insertion at 8-oxo-7,8-dihydroguanine by mammalian DNA polymerase delta. Steady-state and pre-steady-state kinetic analysis. | 2001 Feb 9 |
|
Guanine versus deoxyribose damage in DNA oxidation mediated by vanadium(IV) and vanadium(V) complexes. | 2001 Jan |
|
Protection and in vivo selection of hematopoietic stem cells using temozolomide, O6-benzylguanine, and an alkyltransferase-expressing retroviral vector. | 2001 Jan |
|
Genetic study of SOX9 in a case of campomelic dysplasia. | 2001 Jan 15 |
|
The guanine protein coupled receptor rhodopsin is developmentally regulated in the free-living stages of Schistosoma mansoni. | 2001 Jan 15 |
|
Amino acid residues in ribonuclease MC1 from bitter gourd seeds which are essential for uridine specificity. | 2001 Jan 16 |
|
Structure-activity relationships in flexible protein domains: regulation of rho GTPases by RhoGDI and D4 GDI. | 2001 Jan 5 |
|
New biochemical markers in Alzheimer disease. | 2001 Mar |
|
Metabolism of the beta-oxidized intermediates of N-nitrosodi-n-propylamine: N-nitroso-beta-hydroxypropylpropylamine and N-nitroso-beta-oxopropylpropylamine. | 2001 Mar |
|
Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke. | 2001 Mar |
|
Structure, folding and activity of the VS ribozyme: importance of the 2-3-6 helical junction. | 2001 Mar 15 |
|
Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. | 2001 Mar 30 |
|
Characterization of cDNA encoding the human tRNA-guanine transglycosylase (TGT) catalytic subunit. | 2001 Mar 7 |
|
The Drosophila S3 multifunctional DNA repair/ribosomal protein protects Fanconi anemia cells against oxidative DNA damaging agents. | 2001 Mar 7 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:22:18 GMT 2025
by
admin
on
Mon Mar 31 18:22:18 GMT 2025
|
Record UNII |
5Z93L87A1R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
78695-4
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
NCI_THESAURUS |
C786
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
LOINC |
79690-4
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
||
|
LOINC |
79663-1
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m5869
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB02377
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
73-40-5
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
2127
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
1302156
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
5Z93L87A1R
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
D006147
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
135398634
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
1372539
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | RxNorm | ||
|
GUANINE
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
100000182768
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
DTXSID9052476
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
16235
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
C532
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY | |||
|
200-799-8
Created by
admin on Mon Mar 31 18:22:18 GMT 2025 , Edited by admin on Mon Mar 31 18:22:18 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DERIVATIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
sum of impurities A and B: maximum 2.0 per cent
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
INTERNATIONAL PHARMACOPEIA
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|